Hansoh Pharmaceutical
Hansoh Pharmaceutical Group Company Limited, commonly known as Hansoh Pharmaceutical, is a leading player in the pharmaceutical preparation manufacturing industry, headquartered in China. Established in 1995, the company has made significant strides in developing innovative therapies, particularly in oncology, central nervous system disorders, and autoimmune diseases.
With a strong operational presence across various regions in China and expanding internationally, Hansoh Pharmaceutical is renowned for its commitment to research and development. The company offers a diverse portfolio of products, including high-quality generic drugs and proprietary medicines, distinguished by their efficacy and safety profiles.
Recognised for its rapid growth and market position, Hansoh Pharmaceutical has achieved notable milestones, including numerous product approvals and partnerships that enhance its global reach. As a key contributor to the pharmaceutical landscape, Hansoh continues to focus on advancing healthcare solutions that meet the evolving needs of patients worldwide.
+3 vs industry average
Hansoh Pharmaceutical’s score of 41 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Hansoh Pharmaceutical?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Hansoh Pharmaceutical's reported carbon emissions
Hansoh Pharmaceutical, a company in the Pharmaceutical Preparation Manufacturing industry based in China, has outlined significant climate commitments and reported its carbon emissions.
For the reporting year 2024, Hansoh Pharmaceutical's total calculated greenhouse gas emissions across Scope 1, 2, and 3 were approximately 173.3 million kg CO2e (173,334,600 kg CO2e). This total comprises approximately 11.8 million kg CO2e for Scope 1, approximately 95.4 million kg CO2e for Scope 2 (market-based), and approximately 55.7 million kg CO2e for Scope 3.
The company has set a near-term target to reduce greenhouse gas emissions per unit of revenue from Scope 1 and Scope 2 by 40% by 2030, using 2021 as the base year. Additionally, Hansoh Pharmaceutical aims to decrease comprehensive energy consumption per unit of revenue by 20% by 2030, also with 2021 as the base year. In 2020, the company implemented over 10 energy-saving renovation projects to reduce resource and energy consumption, contributing to emissions reductions.
Hansoh Pharmaceutical's emissions data is cascaded from its parent organisation, Hansoh Pharmaceutical Group Company Limited.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Hansoh Pharmaceutical’s Climate Goals (2030 & 2050)
3 goals2030
40% reduction in Scope 2
By 2030, reduce the greenhouse gas emission per unit of revenue from Scope 1 & Scope 2 by 40%, using 2021 as the base year.
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 3 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
12 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives

Science Based Targets Initiative

Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project